Ensign Peak Advisors’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63M | Hold |
|
|||||
|
2025
Q1 | $2.74M | Sell |
|
|||||
|
2024
Q4 | $7.06M | Buy |
|
|||||
|
2024
Q3 | $4.04M | Buy |
|
|||||
|
2024
Q2 | $744K | Sell |
|
|||||
|
2024
Q1 | $1.17M | Hold |
|
|||||
|
2023
Q4 | $825K | Hold |
|
|||||
|
2023
Q3 | $628K | Hold |
|
|||||
|
2023
Q2 | $798K | Hold |
|
|||||
|
2023
Q1 | $710K | Hold |
|
|||||
|
2022
Q4 | $877K | Sell |
|
|||||
|
2022
Q3 | $1.13M | Buy |
|
|||||
|
2022
Q2 | $1.07M | Hold |
|
|||||
|
2022
Q1 | $1.19M | Buy |
|
|||||
|
2021
Q4 | $142K | Buy |
|
|||||
|
2021
Q3 | $24K | Hold |
|
|||||
|
2021
Q2 | $21K | Hold |
|
|||||
|
2021
Q1 | $25K | Hold |
|
|||||
|
2020
Q4 | $26K | Hold |
|
|||||
|
2020
Q3 | $28K | Buy |
|